Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josef Mautner

Showing results (41-50 of 73) with videos related to

Pageof 8
Sort By:
Plos Pathogens|December 7, 2018
Immunogenic particles with a broad antigenic spectrum stimulate cytolytic T cells and offer increased protection against EBV infection ex vivo and in miceDwain G van Zyl, Ming-Han Tsai, Anatoliy Shumilov, et al.
Analytical and Bioanalytical Chemistry|May 13, 2021
Automated, flow-based chemiluminescence microarray immunoassay for the rapid multiplex detection of IgG antibodies to SARS-CoV-2 in human serum and plasma (CoVRapid CL-MIA)Julia Klüpfel, Rosa Carolina Koros, Kerstin Dehne, et al.
Plos One|August 4, 2012
Humanized c-Myc mouseFrank M Lehmann, Samantha Feicht, Florian Helm, et al.
Cancer Immunology, Immunotherapy : CII|January 29, 2018
Epstein-Barr virus strain heterogeneity impairs human T-cell immunityAna Cirac, Simon Stützle, Michael Dieckmeyer, et al.
The Journal of General Virology|July 23, 2004
Active NF-kappaB signalling is a prerequisite for influenza virus infectionFalk Nimmerjahn, Diana Dudziak, Ulrike Dirmeier, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 28, 2002
MYC overexpression imposes a nonimmunogenic phenotype on Epstein-Barr virus-infected B cellsMartin S Staege, Steven P Lee, Teresa Frisan, et al.
Immunology|October 3, 2012
Isolation of human MHC class II-restricted T cell receptors from the autologous T-cell repertoire with potent anti-leukaemic reactivityLuise U Weigand, Xiaoling Liang, Sabine Schmied, et al.
Journal of Translational Medicine|May 11, 2018
Clinical-grade generation of peptide-stimulated CMV/EBV-specific T cells from G-CSF mobilized stem cell graftsRegina Gary, Michael Aigner, Stephanie Moi, et al.
The Journal of Experimental Medicine|September 14, 2016
Epstein-Barr viral miRNAs inhibit antiviral CD4+ T cell responses targeting IL-12 and peptide processingTakanobu Tagawa, Manuel Albanese, Mickaël Bouvet, et al.
Plos Pathogens|March 14, 2009
An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp/BHRF1 linkGemma L Kelly, Heather M Long, Julianna Stylianou, et al.
Pageof 8

Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
Plos Pathogens|December 7, 2018
Immunogenic particles with a broad antigenic spectrum stimulate cytolytic T cells and offer increased protection against EBV infection ex vivo and in miceDwain G van Zyl, Ming-Han Tsai, Anatoliy Shumilov, et al.
Analytical and Bioanalytical Chemistry|May 13, 2021
Automated, flow-based chemiluminescence microarray immunoassay for the rapid multiplex detection of IgG antibodies to SARS-CoV-2 in human serum and plasma (CoVRapid CL-MIA)Julia Klüpfel, Rosa Carolina Koros, Kerstin Dehne, et al.
Plos One|August 4, 2012
Humanized c-Myc mouseFrank M Lehmann, Samantha Feicht, Florian Helm, et al.
Cancer Immunology, Immunotherapy : CII|January 29, 2018
Epstein-Barr virus strain heterogeneity impairs human T-cell immunityAna Cirac, Simon Stützle, Michael Dieckmeyer, et al.
The Journal of General Virology|July 23, 2004
Active NF-kappaB signalling is a prerequisite for influenza virus infectionFalk Nimmerjahn, Diana Dudziak, Ulrike Dirmeier, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 28, 2002
MYC overexpression imposes a nonimmunogenic phenotype on Epstein-Barr virus-infected B cellsMartin S Staege, Steven P Lee, Teresa Frisan, et al.
Immunology|October 3, 2012
Isolation of human MHC class II-restricted T cell receptors from the autologous T-cell repertoire with potent anti-leukaemic reactivityLuise U Weigand, Xiaoling Liang, Sabine Schmied, et al.
Journal of Translational Medicine|May 11, 2018
Clinical-grade generation of peptide-stimulated CMV/EBV-specific T cells from G-CSF mobilized stem cell graftsRegina Gary, Michael Aigner, Stephanie Moi, et al.
The Journal of Experimental Medicine|September 14, 2016
Epstein-Barr viral miRNAs inhibit antiviral CD4+ T cell responses targeting IL-12 and peptide processingTakanobu Tagawa, Manuel Albanese, Mickaël Bouvet, et al.
Plos Pathogens|March 14, 2009
An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp/BHRF1 linkGemma L Kelly, Heather M Long, Julianna Stylianou, et al.
Pageof 8